These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1785378)

  • 1. Nonhypercalcemic 1,25-(OH)2D3 analogs potently induce the human osteocalcin gene promoter stably transfected into rat osteosarcoma cells (ROSCO-2).
    Morrison NA; Eisman JA
    J Bone Miner Res; 1991 Aug; 6(8):893-9. PubMed ID: 1785378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
    Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
    J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M; Ozono K; Pike JW
    J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx.
    Khoury R; Ridall AL; Norman AW; Farach-Carson MC
    Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
    Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
    J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D metabolites regulate osteocalcin synthesis and proliferation of human bone cells in vitro.
    Skjødt H; Gallagher JA; Beresford JN; Couch M; Poser JW; Russell RG
    J Endocrinol; 1985 Jun; 105(3):391-6. PubMed ID: 3873510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of 22-oxacalcitriol in osteoblast-like (ROS 17/2.8) cells.
    Pernalete N; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Aug; 129(2):778-84. PubMed ID: 1649745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization.
    van Driel M; Koedam M; Buurman CJ; Roelse M; Weyts F; Chiba H; Uitterlinden AG; Pols HA; van Leeuwen JP
    J Cell Biochem; 2006 Oct; 99(3):922-35. PubMed ID: 16741965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
    Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
    J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
    Farach-Carson MC; Sergeev I; Norman AW
    Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic activity of dihydroxylated 19-nor-(pre)vitamin D3.
    Bouillon R; Sarandeses LA; Allewaert K; Zhao J; Mascareñas JL; Mouriño A; Vrielynck S; de Clercq P; Vandewalle M
    J Bone Miner Res; 1993 Aug; 8(8):1009-15. PubMed ID: 8213251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
    Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM
    Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
    J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of 1,25-dihydroxyvitamin D3-analogs on osteoblast-like cells and on in vitro bone resorption.
    van den Bemd GJ; Pols HA; Birkenhäger JC; Kleinekoort WM; van Leeuwen JP
    J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):337-46. PubMed ID: 8541230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity of MC 903 for 1,25-dihydroxyvitamin D receptor and its effects on the synthesis of osteocalcin in human osteosarcoma cells.
    Valaja T; Mahonen A; Pirskanen A; Mäenpää PH
    Biochem Pharmacol; 1990 Oct; 40(8):1827-32. PubMed ID: 2173591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene.
    Morrison NA; Shine J; Fragonas JC; Verkest V; McMenemy ML; Eisman JA
    Science; 1989 Dec; 246(4934):1158-61. PubMed ID: 2588000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.